CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
Balance assessmentsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04914364
NCT04914364N/ACompleted
CompareCT.gov

Describing Balance Function in Patients Post-COVID-19

Duke University·observational·Posted Jun 4, 2021·Updated Sep 19, 2024

In Brief

An observational study evaluating Balance assessments for Covid19. Completed, enrolled 28 participants across 1 site.

Detailed Summary

The purpose of this study is to describe balance deficits in patients post COVID-19. The information the investigators learn may help influence balance training exercises for patients post-COVID-19. Participants will have a primary or secondary diagnosis of COVID-19 during hospitalization and off COVID-19 isolation and be receiving care in an acute inpatient hospital. Following consent, participants will complete balance assessments and questionnaires about balance and dizziness in a single session. Vital signs will be monitored during the session.The greatest risks of this study include shortness of breath, and a risk of falling or musculoskeletal soreness.These risks are no greater than those experienced during a usual physical therapy visit.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCovid19
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJun 4, 2021
Enrollment StartJul 23, 2021
Primary CompletionJun 22, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 5.1 years ago

Interventions

Balance assessmentsother

There is no formal intervention in this study. The investigators will only be completing balance assessments with no follow-up visit.